IMAX stock jumped on Friday after an analyst at Wedbush touted the company as a Covid-19 recovery play.
Pointing to signs of pent-up demand in China, Japan, and elsewhere in Asia for the giant-screen movie theater chain in the first quarter of 2021, Wedbush analyst Alicia Reese raised her rating on IMAX stock (ticker: IMAX) to Outperform from Neutral in a note on Friday. She also bumped up her price target to $26 from $22.
“We…
